Xanthine Oxidase (XO) Inhibition as Therapy for the Interaction Between Developmental Hypoxia and Ageing in Promoting Cardiovascular Disease Risk

被引：0
|
作者：
Allison, B. J. [1 ]
Kane, A. D. [1 ]
Camm, E. J. [1 ]
Lusby, C. [1 ]
Nevin-Dolan, R. [1 ]
Tarry-Adkins, J. L. [1 ]
Ozanne, S. E. [1 ]
Giussani, D. A. [1 ]
机构：
[1] IMS & MRC Unit, Cambridge, England
来源：
REPRODUCTIVE SCIENCES | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-126
引用
收藏
页码：97A / 97A
页数：1
相关论文
共 50 条
  • [1] Xanthine oxidase inhibition for cardiovascular disease prevention
    Tanaka, Atsushi
    Node, Koichi
    [J]. LANCET, 2022, 400 (10359): : 1172 - 1173
  • [2] Developmental Programming of In Vivo Autonomic Dysfunction by Prenatal Hypoxia Is Dependent on Xanthine Oxidase (XO)
    Kane, A. D.
    Lusby, C.
    Giussani, D. A.
    [J]. REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 88A - 89A
  • [3] Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
    Hirotaka Saito
    Kenichi Tanaka
    Tsuyoshi Iwasaki
    Akira Oda
    Shuhei Watanabe
    Makoto Kanno
    Hiroshi Kimura
    Michio Shimabukuro
    Koichi Asahi
    Tsuyoshi Watanabe
    Junichiro James Kazama
    [J]. Scientific Reports, 11
  • [4] Risk Of Cardiovascular Disease and Use Of Xanthine Oxidase Inhibitors For Gout
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    Choudhry, Niteesh
    Liu, Jun
    Glynn, Robert J.
    Solomon, Daniel H.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S729 - S729
  • [5] Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
    Saito, Hirotaka
    Tanaka, Kenichi
    Iwasaki, Tsuyoshi
    Oda, Akira
    Watanabe, Shuhei
    Kanno, Makoto
    Kimura, Hiroshi
    Shimabukuro, Michio
    Asahi, Koichi
    Watanabe, Tsuyoshi
    Kazama, Junichiro James
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
    Feaver, Ryan E.
    Bowers, M. Scott
    Cole, Banumathi K.
    Hoang, Steve
    Lawson, Mark J.
    Taylor, Justin
    LaMoreaux, Brian D.
    Zhao, Lin
    Henke, Brad R.
    Johns, Brian A.
    Nyborg, Andrew C.
    Wamhoff, Brian R.
    Figler, Robert A.
    [J]. PLOS ONE, 2023, 18 (09):
  • [7] Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
    Schuchardt, Mirjam
    Herrmann, Jaqueline
    Toelle, Markus
    van der Giet, Markus
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (23) : 3391 - 3404
  • [8] Xanthine Oxidase Inhibition for the Treatment of Cardiovascular Disease: A Systematic Review and Meta- Analysis
    Zhang, Jufen
    Dierckx, Riet
    Cleland, John G.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 57 - 58
  • [9] Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
    Higgins, Peter
    Dawson, Jesse
    Lees, Kennedy R.
    McArthur, Kate
    Quinn, Terrence J.
    Walters, Matthew R.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) : 217 - 226
  • [10] Programmed Nitric Oxide (NO) Biology by Xanthine Oxidase (XO)-Derived Reactive Oxygen Species (ROS) in an Avian Model of Developmental Hypoxia.
    Beck, C.
    Skeffington, K. L.
    Itani, N.
    Botting, K. J.
    Giussani, D. A.
    [J]. REPRODUCTIVE SCIENCES, 2016, 23 : 230A - 231A
12345